Crossmark

Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes

Crossref DOI link: https://doi.org/10.1186/s13613-023-01150-9

Published Print: 2023

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Mekontso Dessap, Armand https://orcid.org/0000-0001-5961-5577
Papazian, Laurent

Schaller, Manuella

Nseir, Saad

Megarbane, Bruno

Haudebourg, Luc

Timsit, Jean-François

Teboul, Jean-Louis

Kuteifan, Khaldoun

Gainnier, Marc

Slama, Michel

Houeto, Patrick

Lecourt, Laurent

Mercat, Alain

Vieillard-Baron, Antoine
Funding

Funding for this research was provided by:

Air Liquide Healthcare
License Information

Text and Data Mining valid from 2023-01-01

Text and Data Mining valid from 2023-01-01

Version of Record valid from 2025-11-19
More Information

This article is maintained by: Elsevier

Article Title: Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes

Journal Title: Annals of Intensive Care

CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-023-01150-9

Content Type: article

Copyright: Copyright © 2023 The Author(s) 2023. Published by Elsevier Masson SAS